Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 62015

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 06, 2012
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Meridian Medical Technologies a Pfizer Company

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Diazepam Injection, USP, 10 mg Automatic, Autoinjector for Buddy Use, 5 mg/mL, 2 mL autoinjector, 15-count autoinjectors per carton, Rx only, Meridian Medical Technologies, Columbia, MD 21046; A subsidiary of King Pharmaceuticals, Inc.; NSN 6505-01-274-0951, NDC 11704-600-01.

D-1369-2012
Recall number
D-1369-2012
Initiated
June 06, 2012
Classification
Class II
Status
Terminated
Quantity
83,400 autoinjectors

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
Out of Specification

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.

Code information

Lot #: 8D1082, Exp 01/13; 8D1151, Exp 03/13

Distribution pattern

Nationwide, military, Italy, Singapore, Sweden, and Canada.